Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 181–195 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4930 ARHGEF6 Gene (X-Linked Intellectual Disability Type 46) Genetic Test This test analyzes the ARHGEF6 gene for variants associated with X-linked Intellectual Disability Type 46.	Peripheral whole blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARHGEF6 gene sequence", "Single-nucleotide variants (SNVs)", "Small indels"] Parameters [] Preparation ["Clinical history required", "Pre-test genetic counselling required", "Pedigree chart required"] Indications ["Suspected X-linked Intellectual Disability Type 46", "Carrier screening for ARHGEF6 variants", "Differential diagnosis of complex neurological conditions"] Measurement technique Confirm with laboratory Codes LOINC: 50390-2 ICD-10: F78.9 Clinical summary This test analyzes the ARHGEF6 gene for variants associated with X-linked Intellectual Disability Type 46.
TEST-4347 ARHGEF9 Gene (Early Infantile Epileptic Encephalopathy Type 8) NGS Test This test identifies pathogenic variants in the ARHGEF9 gene associated with Early Infantile Epileptic Encephalopathy Type 8 (EIEE8).	Whole Blood (EDTA) or FTA Card	21–28 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in ARHGEF9 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed prior to sample collection"] Indications ["Suspected Early Infantile Epileptic Encephalopathy Type 8 (EIEE8)", "Unexplained severe early-onset seizures", "Developmental delay with seizures"] Measurement technique Confirm with laboratory Codes LOINC: 103735-4 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants in the ARHGEF9 gene associated with Early Infantile Epileptic Encephalopathy Type 8 (EIEE8).
TEST-4618 ARHGEF9 Gene-Related Hyperekplexia & EIEE8 Genetic Test This genetic test identifies pathogenic variants in the ARHGEF9 gene associated with hereditary hyperekplexia and early infantile epileptic encephalopathy type 8.	Whole Blood or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARHGEF9 gene", "Copy Number Variants (CNVs) in ARHGEF9"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history and family pedigree during pre-genetic counselling"] Indications ["Suspected hereditary hyperekplexia", "Suspected early infantile epileptic encephalopathy type 8 (EIEE8)", "Family history of ARHGEF9-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G25.8, G40.8 Clinical summary This genetic test identifies pathogenic variants in the ARHGEF9 gene associated with hereditary hyperekplexia and early infantile epileptic encephalopathy type 8.
TEST-4908 ARID1A Gene Sequencing (Mental Retardation, Autosomal Dominant Type 14) Genetic Test2,800 AED · 2026 DHA Guidelines Test This genetic test analyzes the ARID1A gene to identify pathogenic variants associated with Coffin-Siris syndrome, a neurodevelopmental disorder.	Peripheral whole blood (3–5 mL EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARID1A gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions (within 14 days)"] Indications ["Suspected Coffin-Siris syndrome based on clinical presentation", "Family history of ARID1A-related disorders", "Need for definitive molecular diagnosis for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.89 Clinical summary This genetic test analyzes the ARID1A gene to identify pathogenic variants associated with Coffin-Siris syndrome, a neurodevelopmental disorder.
TEST-4800 ARID1B Gene Sequencing (NGS) Test This diagnostic test evaluates the ARID1B gene for pathogenic variants associated with Autosomal Dominant Intellectual Disability Type 12 and Coffin-Siris Syndrome 1.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3 to 4 Weeks (expedited 2-week option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARID1B gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations (CNV)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9%"}, {"name": "Mean Read Depth", "reference_range": "≥100x"}] Preparation ["Inform laboratory of all current medications, including anti-epileptics, neuroleptics, and melatonin supplements.", "No fasting required.", "Mandatory pre-test genetic counselling session."] Indications ["Suspected Autosomal Dominant Intellectual Disability Type 12", "Suspected Coffin-Siris Syndrome 1", "Family cascade screening for ARID1B variants"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.1, F78.A Clinical summary This diagnostic test evaluates the ARID1B gene for pathogenic variants associated with Autosomal Dominant Intellectual Disability Type 12 and Coffin-Siris Syndrome 1.
TEST-1889 ARL11 Gene Tumor Predisposition Syndrome Test This test evaluates the ARL11 gene for pathogenic variants associated with an increased risk of hereditary cancer predisposition syndromes.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARL11 gene", "Copy Number Variants (CNVs) in the ARL11 gene"] Parameters [{"name": "ARL11 Gene Variants", "reference_range": "No pathogenic or likely pathogenic variants detected"}, {"name": "Copy Number Variants (CNVs)", "reference_range": "No significant CNVs detected"}] Preparation ["No specific fasting required.", "No medication or diet restrictions."] Indications ["Individuals with a personal or family history suggestive of hereditary cancer predisposition syndromes linked to ARL11.", "Assessment of cancer risk in individuals with specific clinical features."] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Z15.09 Clinical summary This test evaluates the ARL11 gene for pathogenic variants associated with an increased risk of hereditary cancer predisposition syndromes.
TEST-4603 ARL13B Gene (Joubert Syndrome Type 8) Genetic Test This test identifies pathogenic variants in the ARL13B gene associated with Joubert syndrome type 8.	Whole Blood (Peripheral) – EDTA tube or FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARL13B gene", "Single-nucleotide variants", "Small insertions/deletions", "Deep intronic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected Joubert syndrome type 8", "Family history of Joubert syndrome", "Characteristic brain MRI findings (molar tooth sign)"] Measurement technique Confirm with laboratory Codes LOINC: 83505-3 ICD-10: Q04.8, Q87.0 Clinical summary This test identifies pathogenic variants in the ARL13B gene associated with Joubert syndrome type 8.
TEST-5796 ARL6IP1 Gene SPG61 Genetic Test This test detects pathogenic variants in the ARL6IP1 gene, confirming a diagnosis of hereditary spastic paraplegia type 61 (SPG61).	Peripheral Whole Blood or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARL6IP1 gene", "Full gene coverage via Next-Generation Sequencing"] Parameters [] Preparation ["No specific fasting required.", "No medication or diet modifications needed prior to sample collection."] Indications ["Diagnosis of hereditary spastic paraplegia type 61 (SPG61)", "Family risk assessment", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 81409-9 ICD-10: G11.4 Clinical summary This test detects pathogenic variants in the ARL6IP1 gene, confirming a diagnosis of hereditary spastic paraplegia type 61 (SPG61).
TEST-5505 ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test This test identifies pathogenic variants in the ARMC4 gene associated with primary ciliary dyskinesia type 23 (PCD23).	Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARMC4 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected primary ciliary dyskinesia", "Family history of PCD", "Recurrent respiratory infections", "Infertility evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 21636-5 ICD-10: Q34.8 Clinical summary This test identifies pathogenic variants in the ARMC4 gene associated with primary ciliary dyskinesia type 23 (PCD23).
TEST-2183 ARNT2 Gene Webb‑Dattani Syndrome Genetic Test This diagnostic test evaluates the ARNT2 gene for pathogenic variants associated with Webb‑Dattani syndrome.	Peripheral blood (EDTA), Saliva (Oragene), or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARNT2 gene coding sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed"] Indications ["Suspected Webb‑Dattani syndrome based on clinical presentation", "Family history of Webb‑Dattani syndrome", "Genetic counseling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 82669-0 ICD-10: Q87.8 Clinical summary This diagnostic test evaluates the ARNT2 gene for pathogenic variants associated with Webb‑Dattani syndrome.
TEST-6003 ARSA Gene Metachromatic Leukodystrophy Genetic Test This genetic test analyzes the ARSA gene to detect mutations associated with Metachromatic Leukodystrophy (MLD). It helps confirm diagnosis, identify carriers, and inform family pl...	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Arylsulfatase A (ARSA) gene pathogenic variants", "Copy number variations in ARSA gene"] Parameters [] Preparation ["No fasting required", "Continue all prescribed medications"] Indications ["Suspected MLD based on clinical symptoms", "Family history of MLD", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 95362-9 ICD-10: E75.23 Clinical summary This genetic test analyzes the ARSA gene to detect mutations associated with Metachromatic Leukodystrophy (MLD). It helps confirm diagnosis, identify carriers, and inform family planning.
TEST-5984 ARSB Gene Mucopolysaccharidosis Type 6 Genetic Test This test identifies pathogenic variants in the ARSB gene associated with Mucopolysaccharidosis Type 6 (Maroteaux-Lamy syndrome). It uses next-generation sequencing to analyze the...	Peripheral Blood, Extracted DNA, or FTA Card (Finger-prick)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARSB gene", "Single-nucleotide resolution across the ARSB coding region"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session"] Indications ["Confirmation of suspected Mucopolysaccharidosis Type 6 (Maroteaux-Lamy syndrome)", "Evaluation of metabolic disorder", "Carrier testing for family members"] Measurement technique Confirm with laboratory Codes LOINC: 94044-9 ICD-10: E76.2 Clinical summary This test identifies pathogenic variants in the ARSB gene associated with Mucopolysaccharidosis Type 6 (Maroteaux-Lamy syndrome). It uses next-generation sequencing to analyze the entire coding region.
TEST-5288 ARSE Gene Chondrodysplasia Punctata, X-Linked Recessive Genetic Test This genetic test sequences the ARSE gene to identify pathogenic variants associated with X-linked recessive chondrodysplasia punctata (CDPX1).	Peripheral Whole Blood or Buccal Swab	21 – 28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARSE gene sequence", "Pathogenic variants in ARSE gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected X-linked recessive chondrodysplasia punctata (CDPX1)", "Family history of CDPX1", "Need to differentiate from other peroxisomal or vitamin K-dependent disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94231-7 ICD-10: Q77.3 Clinical summary This genetic test sequences the ARSE gene to identify pathogenic variants associated with X-linked recessive chondrodysplasia punctata (CDPX1).
TEST-5804 ARSI Gene SPG66 Genetic Test This test analyzes the ARSI gene for pathogenic variants associated with hereditary spastic paraplegia type 66 (SPG66). It utilizes Next-Generation Sequencing (NGS) for high sensit...	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARSI gene sequence", "Pathogenic variants in ARSI gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Suspected hereditary spastic paraplegia type 66", "Family history of SPG66", "Neurological symptoms consistent with SPG66"] Measurement technique Confirm with laboratory Codes LOINC: 95836-5 ICD-10: G11.4 Clinical summary This test analyzes the ARSI gene for pathogenic variants associated with hereditary spastic paraplegia type 66 (SPG66). It utilizes Next-Generation Sequencing (NGS) for high sensitivity and specificity.
TEST-1842 Arthrogryposis and Congenital Myasthenic Syndrome Gene Panel Test This test evaluates for pathogenic genetic variants associated with Arthrogryposis Multiplex Congenita and Congenital Myasthenic Syndromes.	Amniotic fluid, Chorionic villi, or Peripheral blood	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in genes associated with Arthrogryposis Multiplex Congenita", "Pathogenic variants in genes associated with Congenital Myasthenic Syndromes"] Parameters [] Preparation ["No specific fasting required", "Inform physician about all current medications"] Indications ["Suspected diagnosis of Arthrogryposis Multiplex Congenita", "Suspected diagnosis of Congenital Myasthenic Syndrome", "Family history of related genetic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 90280-9 ICD-10: Q74.3, G70.2 Clinical summary This test evaluates for pathogenic genetic variants associated with Arthrogryposis Multiplex Congenita and Congenital Myasthenic Syndromes.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories